Rights and permissions
About this article
Cite this article
Vinorelbine better value than taxanes in breast cancer. Pharmacoecon. Outcomes News 240, 5 (1999). https://doi.org/10.1007/BF03294292
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03294292